Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
The Journal of Clinical Psychiatry
|
March 14, 2000
Approaches to the enhancement of patient adherence to antidepressant medication treatment
P L Delgado
The Journal of Clinical Psychiatry
|
April 25, 2000
Depression: the case for a monoamine deficiency
P L Delgado
Drugs of Today (Barcelona, Spain : 1998)
|
September 16, 2003
Reboxetine: a review of efficacy and tolerability
P L Delgado, T Michaels
The British Journal of Psychiatry. Supplement
|
November 26, 1998
Different roles for serotonin in anti-obsessional drug action and the pathophysiology of obsessive-compulsive disorder
P L Delgado, F A Moreno
The Journal of Clinical Psychiatry
|
March 7, 2000
Role of norepinephrine in depression
P L Delgado, F A Moreno
Bulletin of the Menninger Clinic
|
September 26, 2000
Living with anxiety disorders: as good as it gets...?
F A Moreno, P L Delgado
Journal of Psychoactive Drugs
|
January 30, 1999
Hallucinogens, serotonin and obsessive-compulsive disorder
P L Delgado, F A Moreno
The American Journal of Psychiatry
|
July 1, 1997
Hallucinogen-induced relief of obsessions and compulsions
F A Moreno, P L Delgado
Pharmacopsychiatry
|
January 1, 1996
The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans
G R Heninger, P L Delgado, D S Charney
International Clinical Psychopharmacology
|
November 1, 1993
The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders
R M Salomon, H L Miller, P L Delgado, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
The Journal of Clinical Psychiatry
|
March 14, 2000
Approaches to the enhancement of patient adherence to antidepressant medication treatment
P L Delgado
The Journal of Clinical Psychiatry
|
April 25, 2000
Depression: the case for a monoamine deficiency
P L Delgado
Drugs of Today (Barcelona, Spain : 1998)
|
September 16, 2003
Reboxetine: a review of efficacy and tolerability
P L Delgado, T Michaels
The British Journal of Psychiatry. Supplement
|
November 26, 1998
Different roles for serotonin in anti-obsessional drug action and the pathophysiology of obsessive-compulsive disorder
P L Delgado, F A Moreno
The Journal of Clinical Psychiatry
|
March 7, 2000
Role of norepinephrine in depression
P L Delgado, F A Moreno
Bulletin of the Menninger Clinic
|
September 26, 2000
Living with anxiety disorders: as good as it gets...?
F A Moreno, P L Delgado
Journal of Psychoactive Drugs
|
January 30, 1999
Hallucinogens, serotonin and obsessive-compulsive disorder
P L Delgado, F A Moreno
The American Journal of Psychiatry
|
July 1, 1997
Hallucinogen-induced relief of obsessions and compulsions
F A Moreno, P L Delgado
Pharmacopsychiatry
|
January 1, 1996
The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans
G R Heninger, P L Delgado, D S Charney
International Clinical Psychopharmacology
|
November 1, 1993
The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders
R M Salomon, H L Miller, P L Delgado, et al.
Page
of 6